Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • WhatsOEver
    Senior Member
    • Apr 2012
    • 215

    Strange genotypes from single cell variant calling using monovar

    Hi @all,

    I'd like whether anyone has some experience with monovar (http://www.nature.com/nmeth/journal/...meth.3835.html)

    I'm asking because multi sample genotyping doesn't seem to work probably. Here are two of many examples of to illustrate the problem:

    0/1:425,1:428:2:4,2,3240
    0/1:705,1:706:2:4,2,3240
    0/1:239,0:240:2:4,2,3240
    1/1:8,145:154:7:3240,12,0
    1/1:1,248:249:7:3240,12,0
    1/1:2,57:59:7:1486,12,0
    1/1:2,118:120:7:3240,12,0
    1/1:1,27:28:7:693,12,0
    1/1:2,36:38:7:915,12,0
    1/1:0,8:8:7:224,12,0
    1/1:1,47:48:7:1248,12,0
    1/1:0,76:76:7:2046,12,0
    1/1:0,64:64:7:1724,12,0
    1/1:0,116:116:7:3240,12,0
    1/1:0,13:13:7:355,12,0

    The first 3 records are controls, the remaining tumor cells. For me it looks like the algo assumes an ADO in those records simply because there are more hom alt calls?! But what is the logic behind this assumption?

    It seems to work fine if you have a better mixture of genotypes
    0/1:22,51:73:3:1127,0,357
    0/1:63,44:108:3:847,0,1346
    0/1:11,47:59:3:1064,0,109
    0/0:38,0:38:4:1,5,996
    ./.
    0/0:144,0:144:4:1,5,3240
    0/0:19,0:19:4:1,5,500
    1/1:0,117:117:4:3240,8,1
    1/1:0,1:1:2:31,4,3
    1/1:0,78:78:4:2062,8,1
    1/1:0,54:54:4:1421,8,1
    1/1:0,167:167:4:3240,8,1
    1/1:0,74:74:4:1960,8,1
    1/1:0,320:321:4:3240,8,1
    1/1:0,104:104:4:3240,8,1

    The big question for me is know, how do I filter unreliable values? Depth was my first choice, but its probably not sufficient. Quality seems to be always low, especially if ADOs might have occurred (so in case where the GT is hom alt or hom ref...) But then, only hets with a strong difference in the likelihoods are reliable and everything not...

    Any ideas or suggestions are welcome

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 11:41 AM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
34 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
44 views
0 reactions
Last Post SEQadmin2  
Working...